Surgical management of metachronous bronchial carcinoma

被引:27
作者
Doddoli, C [1 ]
Thomas, P [1 ]
Ghez, O [1 ]
Giudicelli, R [1 ]
Fuentes, P [1 ]
机构
[1] St Marguerite Univ Hosp, Dept Thorac Surg, Marseille, France
关键词
second primary lung cancer; resection; follow-up;
D O I
10.1016/S1010-7940(01)00690-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the results of surgery for the treatment of metachronous bronchial carcinoma. Methods: From 1985 to 1999, 38 patients were operated on fur a metachronous lung carcinoma, accordingly to the criteria of Martini. All tumors were staged using the new International Classification System revised in 1997. Results: Diagnosis of the second cancer was done at radiological follow-up in 30 asymptomatic patients. Seventeen metachronous locations were ipsilateral. Histology of the metachronous lesion was the same as that of the first tumour in 23 patients (60%). The first resection was a lobectomy (n = 35), a pneumonectomy (n = 2) and a carinal resection (n = 1). The second one was a wedge resection (n = 7), a segmentectomy (n = 3), a lingulectomy (n = 2), a lobectomy (n = 9), a bilobectomy (n = 1), and a pneumonectomy (n = 16). There were Live in-hospital deaths (13%). Completion pneumonectomy was performed in 15 patients, with one postoperative death (7%). The overall estimated 5 and 10-years actuarial survival rates from the treatment of the first cancer were 70 and 47% respectively. The 5-year survival rate after the treatment of the second cancer was 32% (median survival: 31 months), including the operative mortality, Survival was negatively affected by a resection interval of less than 2 years and the performance of atypical lung sparing pulmonary resection for the treatment of the second cancer. Conclusions: Good long-term results are achievable by the means of a second pulmonary resection in selected patients with metachronous lung cancer. Optimal cancer operations should he applied whenever functionally possible. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:899 / 903
页数:5
相关论文
共 17 条
[1]   2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP [J].
ANGELETTI, CA ;
MUSSI, A ;
JANNI, A ;
LUCCHI, M ;
RIBECHINI, A ;
CHELLA, A ;
FONTANINI, G .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1995, 9 (11) :607-611
[2]   2ND PRIMARY LUNG-CANCER [J].
ANTAKLI, T ;
SCHAEFER, RF ;
RUTHERFORD, JE ;
READ, RC .
ANNALS OF THORACIC SURGERY, 1995, 59 (04) :863-867
[3]  
DESCHAMPS C, 1990, J THORAC CARDIOV SUR, V99, P769
[4]   Synchronous and metachronous lung carcinomas: Molecular evidence for multicentricity [J].
Hiroshima, K ;
Toyozaki, T ;
Kohno, H ;
Ohwada, H ;
Fujisawa, T .
PATHOLOGY INTERNATIONAL, 1998, 48 (11) :869-876
[5]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[6]   DNA PLOIDY PATTERNS OF TUMORS DIAGNOSED AS METACHRONOUS OR RECURRENT LUNG CANCERS [J].
ICHINOSE, Y ;
HARA, N ;
OHTA, M ;
KUDA, T ;
ASOH, H ;
CHIKAMA, H .
ANNALS OF THORACIC SURGERY, 1991, 52 (03) :469-473
[7]  
Johnson BE, 1997, SEMIN ONCOL, V24, P492
[8]  
Levi F, 1999, CANCER, V86, P186, DOI 10.1002/(SICI)1097-0142(19990701)86:1<186::AID-CNCR25>3.0.CO
[9]  
2-3
[10]  
MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606